Wild that when Celcuity went public in '17 it was a diagnostics company

In '21 licensed a drug from Pfizer that was in Phase 1b trials. Will now likely be a 1B+ plus asset and a step change for those with certain types of locally advanced/metastatic BC

Not a bad pivot!